January 3, 2026 · Form 4 insider transaction
Snyder Mark Howard sold 4,243 shares of Halozyme Therapeutics, Inc. at $70.31 per share, a transaction worth $298.3K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 3 days after the transaction.
The reported disposition of 4,243 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.